Application of water-soluble yeast beta-glucan in preparation of anti-inflammatory product

The invention relates to the technical field of medicines, in particular to application of water-soluble yeast beta-glucan in preparation of anti-inflammatory products. Specifically, the invention provides application of water-soluble yeast beta-glucan in preparation of anti-inflammatory products, wherein glucan with the relative molecular weight smaller than or equal to 10000 Da accounts for 65% or above of the total mass of glucan. Results of influence experiments on survival rate and NO secretion of mouse macrophage RAW264.7 show that the water-soluble yeast beta-glucan with the molecular weight smaller than or equal to 10000 Da and accounting for more than 65% of the total mass of glucan is nontoxic to RAW264.7 cells when the concentration is lower than 400 [mu] g/mL, the situation that LPS-induced NO release in RAW264.7 is increased can be improved, and inflammatory response is reduced..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 17. März Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

PENG YING [VerfasserIn]
XIAO MINGHUA [VerfasserIn]
LI PEI [VerfasserIn]
LI KU [VerfasserIn]
YAN DONGFANG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23L: Foods, foodstuffs, or non-alcoholic beverages, not (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-03-17, Last update posted on www.tib.eu: 2023-06-21, Last updated: 2023-06-30

Patentnummer:

CN115804789

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01734235X